Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines

Vaccine

Volumn 15, Issue 2, 1997, Pages 195-202

  Mader, Horst J ^a   Szostak, Michael P ^a   Hensel, Andreas ^a   Lubitz, Werner ^a   Haslberger, Alexander G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antigenicity; Bacterial ghosts; Endotoxicity; Rabbits; RAW mouse macrophages

Indexed keywords

ENDOTOXIN; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; BACTERIAL CELL WALL; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SALMONELLA TYPHIMURIUM; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CELL LINE; CELL WALL; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENDOTOXINS; ESCHERICHIA COLI; INJECTIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PYROGENS; RABBITS; SALMONELLA TYPHIMURIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031081378     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00141-7     Document Type: Article

References (29)

1. 1 Szostak, M.P., Hensel, A., Eko, F.O. et al. Bacterial ghosts: non-living canditate vaccines. J. Biotechn. 1996, 44, 161-170
2. 2 Witte, A., Wanner, G., Bläsi, U., Halfmann, G., Szostak, M. and Lubitz, W. Endogenous transmembrane tunnel formation mediated by PhiX174 lysis protein. J. Bact. 1990, 172, 4109-4114
3. 3 Witte, A., Wanner, G., Sulzner, M. and Lubitz, W. Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli. Arch. Microbiol. 1992, 157, 381-388
4. 4 Szostak, M. and Lubitz, W. Recombinant bacterial ghosts as multivaccine vehicles. In: Vaccines 91: Modern Approaches to New Vaccines including Prevention of AIDS (Eds Chanock, R.M. et al.). Cold Spring Harbor Laboratory Press, New York, pp. 409-414
5. 5 Szostak, M., Auer, T. and Lubitz, W. Immune response against recombinant bacterial ghosts carrying HIV-1 reverse transcriptase. In: Vaccines 93: Modern Approaches to New Vaccines including Prevention of AIDS (Eds Chanock, R.M. et al.). Cold Spring Harbor Laboratory Press, New York, pp. 419-425
6. 6 Hensel, A., van Leengoed, L.A.M.G., Szostak, M. et al. Induction of protective immunity by aresol or oral application of candidate vaccines in dose-controlled pig aerosol infection model. J. Biotechn. 1996, 44, 171-181
7. 7 Galanos, C. and Freudenberg, M.A. Mechanism of endotoxin shock and endotoxin hypersensitivity. Immunobiology 1993, 187, 346-356
8. 8 Martich, G.D., Boujoukos, A.J. and Suffredini, A.F. Response of man to endotoxin. Immunobiology 1993, 187, 403-416
9. 9 Freudenberg, M.A. and Galanos, C. Bacterial lipopolysaccharides: structure, metabolism and mechanism of action. Int. Rev. Immun. 1990, 6, 207-221
10. 10 Shumann, R.R., Leong, S.R., Flaggs, G.W. et al. Structure and function of lipopolysaccharide binding protein. Science 1990, 249, 1429-1431
11. 11 Frey, E.A., Miller, D.S., Jahr, T.G. et al. Soluble CD14 participates in the responses of cells to lipopolysaccharide. J. exp. Med. 1992, 176, 1656-1671
12. 12 Treon, S.P., Thomas, P. and Broitman, S.A. Lipopolysaccharide (LPS) processing by Kupffer cells releases a modified LPS with increased hepatocyte binding and decreased tumour necrosis factor-alpha stimulatory capacity. Proc. Soc. exp. Biol. Med. 1993, 202, 153-158
13. 13 Iwanga, S. Chromogenic substrate for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins. Haemostasis 1987, 7, 183
14. 14 Karkhanis, Y.D., Zeltner, J.Y., Jackson, J.J. and Carl, D.J. A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopoly-saccharide of Gram-negative bacteria Analyt. Biochem. 1977, 85, 595-601
15. 15 Raschke, W.C., Baird, S., Ralph, P. and Nakoinz, I. Functional macrophage cell lines transformed by Abelson Leukemia virus. Cell 1978, 15, 261-267
16. 16 Haslberger, A., Romanin, C. and Koerber, R. Membrane potential release of tumour necrosis factor in lipopolysaccnaride-stimulated mouse macrophages. Mol. biol. Cell. 1992, 3, 451-460
17. 17 Henning, U., Rehn, K. and Hoehn, B. Cell envelope and shape of Escherichia Coli K12. Proc. natn Acad. Sci. U.S.A. 1973, 70, 2033-2036
18. 18 Mühlradt, P.F. and Golecki, J.R. Asymmetrical distribution and artificial reorientation of lipopolysaccharide in the outer membrane bilayer of Salmonella typhimurium. Eur. J. Biochem. 1975, 51, 343-352
19. 19 Witte, A., Wanner, G., Lubitz, W. and Höltje, J.-V. Effect of Phix174 E-mediated lysis on murein composition of Escherichia coli. Eur. J. Biochem. (in press)
20. 20 Eko, F.O., Hensel, A., Bunka, S. and Lubitz, W. Immunogenicity of Vibrio cholerae ghosts following intraperitoneal immunization of mice. Vaccine 1994, 12, 1330-1334
21. 21 Morrison, D.C. and Ryan, J.L. Endotoxins and disease mechanisms. A. Rev. Med. 1987, 38, 417-432
22. 22 Izui, S., Eisenberg, R.A. and Dixon, F.J. Subclass-restricted IgG polyclonal antibody production in mice injected with lipid A-rich lipopolysaccharides. J. exp. Med. 1981, 153, 324-338
23. 23 Proctor, R.A. (Ed.). Handbook of Endotoxin 4. Elsevier Biomedical Press, Amsterdam, 1986
24. 24 Nencioni, L., Pizza, M., Bugnoli, M. et al. Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough. Infect. Immun. 1991, 59, 625-630
25. 25 Ferguson, M., Wood, D.J. and Minor, P.D. Antigenic structure of poliovirus in inactivated vaccines. J. Gen. Virol. 1993, 74, 685-690
26. 26 Lam, J.S., Granoff, D.M., Gilsdorf, J.R. and Costerton, J.W. Immunogenicity of outer membrane derivatives of Haemophilus influenzae Type b. Curr. Microbiol. 1980, 3, 359-364
27. 27 Schön, P., Schrot, G., Wenner, G., Lubitz, W. and Witte, A. Two-stage model for integration of the lysis protein E of Phi X174 into the cell envelope of Escherichia coli. FEMS Microbiol Rev. 1995, 17, 207-212
28. 28 Di Padova, F.E., Brade, H., Barclay, G.R. et al. A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infect. Immun. 1993, 61, 3836-3872
29. 29 Freudenberg, M.A. and Galanos, C. Tumour necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect. Immun. 1991, 59, 2110-2115